{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T09:08:17Z","timestamp":1789031297557,"version":"build-2803163510"},"reference-count":40,"publisher":"Portland Press Ltd.","issue":"10","license":[{"start":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T00:00:00Z","timestamp":1787788800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000057","name":"HHS | NIH | National Institute of General Medical Sciences","doi-asserted-by":"publisher","award":["R01 GM121515"],"award-info":[{"award-number":["R01 GM121515"]}],"id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["portlandpress.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,10,7]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>The cyclin-dependent kinases (CDKs) regulate cell cycle progression subject to strict control by activating cyclin subunits and by site-specific phosphorylation on the activation loop. These mechanisms are highly conserved across eukaryotic organisms. The non-canonical CDK activator Speedy A (SPY1) is unrelated in sequence to the cyclins and activates CDK2 in G1\/S phase in somatic cells and promotes meiosis in germ cells without requiring activation-loop phosphorylation of CDK2 on T160. This has been attributed to a single aspartic acid residue of SPY1 (D136) that mimics T160 phosphorylation by forming similar salt-bridging interactions that stabilize the active conformation of the SPY1\u2013CDK2 complex. Here, we show that SPY1 activates both phosphorylated and unphosphorylated CDK2 with similar efficacy to its canonical activator CyclinA. FRET experiments show that SPY1 binding causes a similar magnitude of CDK2 conformational shift to that triggered by CyclinA binding to phosphorylated CDK2, but regardless of the kinase phosphorylation state. SPY1 binding allosterically enhances binding of ATP-competitive CDK2 inhibitors to a similar degree as CyclinA, resulting in similarly high-affinity inhibitor binding and inhibition. Remarkably, we found that the D136A mutant of SPY1, while inactive towards unphosphorylated CDK2, can still activate phosphorylated CDK2 as effectively as WT SPY1, demonstrating functional non-equivalence of its two activation mechanisms.<\/jats:p>","DOI":"10.1042\/bcj20260441","type":"journal-article","created":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T13:32:58Z","timestamp":1787837578000},"page":"1917-1929","update-policy":"https:\/\/doi.org\/10.1042\/crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["The non-canonical CDK2 activator SPY1 uses separable mechanisms to activate phosphorylated and unphosphorylated CDK2"],"prefix":"10.1042","volume":"483","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6114-9659","authenticated-orcid":false,"given":"Liam\u00a0P.","family":"Fawcett","sequence":"first","affiliation":[{"name":"1Department of Pharmacology, University of Minnesota, Minneapolis, MN 55455, U.S.A."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4338-8087","authenticated-orcid":false,"given":"Nicholas\u00a0M.","family":"Levinson","sequence":"additional","affiliation":[{"name":"1Department of Pharmacology, University of Minnesota, Minneapolis, MN 55455, U.S.A."},{"name":"2Masonic Cancer Center, University of Minnesota, Minneapolis, MN 55455, U.S.A."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"288","published-online":{"date-parts":[[2026,9,10]]},"reference":[{"key":"2026091004264710500_B1","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1038\/s41586-022-04798-8","article-title":"Core control principles of the eukaryotic cell cycle","volume":"607","author":"Basu","year":"2022","journal-title":"Nature"},{"key":"2026091004264710500_B2","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1128\/MCB.15.1.345","article-title":"Effects of phosphorylation by CAK on cyclin binding by CDC2 and CDK2","volume":"15","author":"Desai","year":"1995","journal-title":"Mol. Cell. Biol."},{"key":"2026091004264710500_B3","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1016\/j.molcel.2007.02.003","article-title":"Requirements for Cdk7 in the assembly of Cdk1\/cyclin B and activation of Cdk2 revealed by chemical genetics in human cells","volume":"25","author":"Larochelle","year":"2007","journal-title":"Mol. Cell"},{"key":"2026091004264710500_B4","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1038\/366701a0","article-title":"p21 is a universal inhibitor of cyclin kinases","volume":"366","author":"Xiong","year":"1993","journal-title":"Nature"},{"key":"2026091004264710500_B5","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1038\/366704a0","article-title":"A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D\/CDK4","volume":"366","author":"Serrano","year":"1993","journal-title":"Nature"},{"key":"2026091004264710500_B6","doi-asserted-by":"publisher","first-page":"180112","DOI":"10.1098\/rsob.180112","article-title":"Structural insights into the functional diversity of the CDK\u2013cyclin family","volume":"8","author":"Wood","year":"2018","journal-title":"Open Biol."},{"key":"2026091004264710500_B7","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1038\/363595a0","article-title":"Crystal structure of cyclin-dependent kinase 2","volume":"363","author":"De Bondt","year":"1993","journal-title":"Nature"},{"key":"2026091004264710500_B8","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1038\/376313a0","article-title":"Mechanism of CDK activation revealed by the structure of a cyclinA\u2013CDK2 complex","volume":"376","author":"Jeffrey","year":"1995","journal-title":"Nature"},{"key":"2026091004264710500_B9","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1038\/nsb0896-696","article-title":"Structural basis of cyclin-dependent kinase activation by phosphorylation","volume":"3","author":"Russo","year":"1996","journal-title":"Nat. Struct. Biol."},{"key":"2026091004264710500_B10","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1126\/science.270.5233.90","article-title":"Dephosphorylation of Cdk2 Thr160 by the cyclin-dependent kinase-interacting phosphatase KAP in the absence of cyclin","volume":"270","author":"Poon","year":"1995","journal-title":"Science"},{"key":"2026091004264710500_B11","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1038\/sj.emboj.7600554","article-title":"The structure of cyclin E1\/CDK2: implications for CDK2 activation and CDK2-independent roles","volume":"24","author":"Honda","year":"2005","journal-title":"EMBO J."},{"key":"2026091004264710500_B12","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1038\/382325a0","article-title":"Crystal structure of the p27Kip1 cyclin-dependent-kinase inhibitor bound to the cyclin A-Cdk2 complex","volume":"382","author":"Russo","year":"1996","journal-title":"Nature"},{"key":"2026091004264710500_B13","doi-asserted-by":"publisher","first-page":"1907","DOI":"10.1038\/emboj.2008.121","article-title":"The structure of P-TEFb (CDK9\/cyclin T1), its complex with flavopiridol and regulation by phosphorylation","volume":"27","author":"Baumli","year":"2008","journal-title":"EMBO J."},{"key":"2026091004264710500_B14","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1038\/s41523-022-00494-y","article-title":"Crystal structure of active CDK4-cyclin D and mechanistic basis for abemaciclib efficacy","volume":"8","author":"Gharbi","year":"2022","journal-title":"NPJ Breast Cancer"},{"key":"2026091004264710500_B15","doi-asserted-by":"publisher","first-page":"5718","DOI":"10.1038\/s41467-026-72329-4","article-title":"Cryo-EM structures of the CDK11-cyclin L-SAP30BP complex reveal mechanisms of CDK11 regulation","volume":"17","author":"McGeoch","year":"2026","journal-title":"Nat. Commun."},{"key":"2026091004264710500_B16","doi-asserted-by":"publisher","first-page":"1869","DOI":"10.1093\/emboj\/18.7.1869","article-title":"Speedy: a novel cell cycle regulator of the G2\/M transition","volume":"18","author":"Lenormand","year":"1999","journal-title":"EMBO J."},{"key":"2026091004264710500_B17","doi-asserted-by":"publisher","first-page":"2177","DOI":"10.1101\/gad.13.16.2177","article-title":"A novel p34(cdc2)-binding and activating protein that is necessary and sufficient to trigger G(2)\/M progression in Xenopus oocytes","volume":"13","author":"Ferby","year":"1999","journal-title":"Genes Dev."},{"key":"2026091004264710500_B18","doi-asserted-by":"publisher","first-page":"155","DOI":"10.4161\/cc.4.1.1347","article-title":"Identification and comparative analysis of multiple mammalian Speedy\/Ringo proteins","volume":"4","author":"Cheng","year":"2005","journal-title":"Cell Cycle"},{"key":"2026091004264710500_B19","doi-asserted-by":"publisher","first-page":"3835","DOI":"10.1007\/s00018-012-1050-1","article-title":"Evolution of the Cdk-activator Speedy\/RINGO in vertebrates","volume":"69","author":"Chauhan","year":"2012","journal-title":"Cell. Mol. Life Sci."},{"key":"2026091004264710500_B20","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1083\/jcb.200109045","article-title":"Human Speedy: a novel cell cycle regulator that enhances proliferation through activation of Cdk2","volume":"157","author":"Porter","year":"2002","journal-title":"J. Cell Biol."},{"key":"2026091004264710500_B21","doi-asserted-by":"publisher","first-page":"36028","DOI":"10.1074\/jbc.M104722200","article-title":"Differential regulation of Cdc2 and Cdk2 by RINGO and cyclins","volume":"276","author":"Karaiskou","year":"2001","journal-title":"J. Biol. Chem."},{"key":"2026091004264710500_B22","doi-asserted-by":"publisher","first-page":"2251","DOI":"10.15252\/embj.201796905","article-title":"Structural basis of divergent cyclin-dependent kinase activation by Spy1\/RINGO proteins","volume":"36","author":"McGrath","year":"2017","journal-title":"EMBO J."},{"key":"2026091004264710500_B23","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/1471-2091-6-19","article-title":"Biochemical characterization of Cdk2-Speedy\/Ringo A2","volume":"6","author":"Cheng","year":"2005","journal-title":"BMC Biochem."},{"key":"2026091004264710500_B24","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1073\/pnas.1618465114","article-title":"Speedy A-Cdk2 binding mediates initial telomere-nuclear envelope attachment during meiotic prophase I independent of Cdk2 activation","volume":"114","author":"Tu","year":"2017","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"2026091004264710500_B25","doi-asserted-by":"publisher","first-page":"50956","DOI":"10.1074\/jbc.M306546200","article-title":"Substrate specificity of CDK2-cyclin A. What is optimal?","volume":"278","author":"Stevenson-Lindert","year":"2003","journal-title":"J. Biol. Chem."},{"key":"2026091004264710500_B26","doi-asserted-by":"publisher","first-page":"168952","DOI":"10.1016\/j.jmb.2025.168952","article-title":"Differences in binding affinity among cell-cycle CDK and cyclin pairs","volume":"437","author":"Putta","year":"2025","journal-title":"J. Mol. Biol."},{"key":"2026091004264710500_B27","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1038\/s41589-020-00725-y","article-title":"Allostery governs Cdk2 activation and differential recognition of CDK inhibitors","volume":"17","author":"Majumdar","year":"2021","journal-title":"Nat. Chem. Biol."},{"key":"2026091004264710500_B28","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.chembiol.2018.10.015","article-title":"Differences in the conformational energy landscape of CDK1 and CDK2 suggest a mechanism for achieving selective CDK inhibition","volume":"26","author":"Wood","year":"2019","journal-title":"Cell Chem. Biol."},{"key":"2026091004264710500_B29","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1042\/BJ20041779","article-title":"Characterization of a new family of cyclin-dependent kinase activators","volume":"386","author":"Dinarina","year":"2005","journal-title":"Biochem. J."},{"key":"2026091004264710500_B30","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1038\/15674","article-title":"The structural basis for specificity of substrate and recruitment peptides for cyclin-dependent kinases","volume":"1","author":"Brown","year":"1999","journal-title":"Nat. Cell Biol."},{"key":"2026091004264710500_B31","doi-asserted-by":"publisher","first-page":"3176","DOI":"10.1038\/s41467-021-23550-w","article-title":"The SUN1-SPDYA interaction plays an essential role in meiosis prophase I","volume":"12","author":"Chen","year":"2021","journal-title":"Nat. Commun."},{"key":"2026091004264710500_B32","doi-asserted-by":"publisher","first-page":"18164","DOI":"10.1021\/acs.jmedchem.5c01478","article-title":"Discovery of AZD8421: a potent CDK2 inhibitor with selectivity against other CDK family members and the human kinome","volume":"68","author":"Ghosh","year":"2025","journal-title":"J. Med. Chem."},{"key":"2026091004264710500_B33","doi-asserted-by":"publisher","first-page":"1297","DOI":"10.1158\/0008-5472.CAN-24-2360","article-title":"Profiling the activity of the potent and highly selective CDK2 inhibitor BLU-222 reveals determinants of response in CCNE1-aberrant ovarian and endometrial tumors","volume":"85","author":"House","year":"2025","journal-title":"Cancer Res."},{"key":"2026091004264710500_B34","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1083\/jcb.200204155","article-title":"Human TPX2 is required for targeting Aurora-A kinase to the spindle","volume":"158","author":"Kufer","year":"2002","journal-title":"J. Cell Biol."},{"key":"2026091004264710500_B35","doi-asserted-by":"publisher","first-page":"E11894","DOI":"10.1073\/pnas.1811158115","article-title":"Quantitative conformational profiling of kinase inhibitors reveals origins of selectivity for Aurora kinase activation states","volume":"115","author":"Lake","year":"2018","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"2026091004264710500_B36","doi-asserted-by":"publisher","first-page":"3213","DOI":"10.1038\/s41467-023-38732-x","article-title":"Development of allosteric and selective CDK2 inhibitors for contraception with negative cooperativity to cyclin binding","volume":"14","author":"Faber","year":"2023","journal-title":"Nat. Commun."},{"key":"2026091004264710500_B37","doi-asserted-by":"publisher","first-page":"2545","DOI":"10.1091\/mbc.9.9.2545","article-title":"Human and yeast cdk-activating kinases (CAKs) display distinct substrate specificities","volume":"9","author":"Kaldis","year":"1998","journal-title":"Mol. Biol. Cell"},{"key":"2026091004264710500_B38","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1016\/bs.mie.2015.06.006","article-title":"mtsslSuite: probing biomolecular conformation by spin-labeling studies","volume":"563","author":"Hagelueken","year":"2015","journal-title":"Methods Enzymol."},{"key":"2026091004264710500_B39","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1177\/1087057116679637","article-title":"Spectral unmixing plate reader: high-throughput, high-precision FRET assays in living cells","volume":"22","author":"Schaaf","year":"2017","journal-title":"SLAS Discov."},{"key":"2026091004264710500_B40","doi-asserted-by":"publisher","first-page":"e57264","DOI":"10.7554\/eLife.57264","article-title":"How to measure and evaluate binding affinities","volume":"9","author":"Jarmoskaite","year":"2020","journal-title":"Elife"}],"container-title":["Biochemical Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/portlandpress.com\/biochemj\/article-pdf\/483\/10\/1917\/991516\/bcj-2026-0441.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/portlandpress.com\/biochemj\/article-pdf\/483\/10\/1917\/991516\/bcj-2026-0441.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T08:26:52Z","timestamp":1789028812000},"score":1,"resource":{"primary":{"URL":"https:\/\/portlandpress.com\/biochemj\/article\/483\/10\/1917\/237992\/The-non-canonical-CDK2-activator-SPY1-uses"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,10]]},"references-count":40,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026,10,7]]}},"URL":"https:\/\/doi.org\/10.1042\/bcj20260441","relation":{},"ISSN":["0264-6021","1470-8728"],"issn-type":[{"value":"0264-6021","type":"print"},{"value":"1470-8728","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,10]]},"published":{"date-parts":[[2026,9,10]]}}}